Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

BMPR2 antibody (AA 455-512)

There are 2+ publications for this product available. The Rabbit Polyclonal anti-BMPR2 antibody is suitable to detect BMPR2 in samples from Human, Mouse and Rat. It has been validated for WB and ELISA.
Catalog No. ABIN5693167
$370.00
Plus shipping costs $50.00
100 μg
Shipping to: United States
Delivery in 4 to 7 Business Days

Quick Overview for BMPR2 antibody (AA 455-512) (ABIN5693167)

Target

See all BMPR2 Antibodies
BMPR2 (Bone Morphogenetic Protein Receptor, Type II (serine/threonine Kinase) (BMPR2))

Reactivity

  • 54
  • 33
  • 9
  • 3
  • 1
Human, Mouse, Rat

Host

  • 45
  • 8
  • 1
Rabbit

Clonality

  • 46
  • 8
Polyclonal

Conjugate

  • 33
  • 2
  • 2
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
This BMPR2 antibody is un-conjugated

Application

  • 47
  • 26
  • 18
  • 15
  • 13
  • 13
  • 9
  • 9
  • 7
  • 4
  • 1
  • 1
Western Blotting (WB), ELISA
  • Binding Specificity

    • 15
    • 10
    • 8
    • 4
    • 3
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    AA 455-512

    Purpose

    Anti-BMPR2 Antibody

    Cross-Reactivity (Details)

    No cross-reactivity with other proteins.

    Characteristics

    Anti-BMPR2 Antibody (ABIN5693167). Tested in ELISA, WB applications. This antibody reacts with Human, Mouse, Rat. This is a premium antibody that guarantees superior quality, high affinity, and strong signals with minimal background in Western blot applications.

    Purification

    Immunogen affinity purified.

    Immunogen

    E. coli-derived human BMPR2 recombinant protein (Position: R455-K512).

    Isotype

    IgG
  • Application Notes

    Western blot, 0.1-0.5 μg/mL
    ELISA, 0.1-0.5 μg/mL

    Restrictions

    For Research Use only
  • Format

    Lyophilized

    Reconstitution

    Add 0.2 mL of distilled water will yield a concentration of 500 μg/mL.

    Concentration

    500 μg/mL

    Buffer

    Each vial contains 4 mg Trehalose, 0.9 mg NaCl, 0.2 mg Na2HPO4, 0.05 mg NaN3.

    Preservative

    Sodium azide

    Precaution of Use

    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

    Storage

    4 °C,-20 °C

    Storage Comment

    Store at -20°C for one year from date of receipt. After reconstitution, at 4°C for one month.
    It can also be aliquotted and stored frozen at -20°C for six months. Avoid repeated freeze-thaw cycles.
  • Hanusek, Rybicka, Popławski, Adamiok-Ostrowska, Głuchowska, Piekiełko-Witkowska, Bogusławska: "TGF‑β1 affects the renal cancer miRNome and regulates tumor cells proliferation." in: International journal of molecular medicine, Vol. 49, Issue 4, (2022) (PubMed).

    Liu, Zhong, Yuan, Chen, Zhou, An, Guo, Fan, Li, Sun, Li, Shi, Weng: "MicroRNA-155 inhibits the osteogenic differentiation of mesenchymal stem cells induced by BMP9 via downregulation of BMP signaling pathway." in: International journal of molecular medicine, Vol. 41, Issue 6, pp. 3379-3393, (2018) (PubMed).

  • Target

    BMPR2 (Bone Morphogenetic Protein Receptor, Type II (serine/threonine Kinase) (BMPR2))

    Alternative Name

    BMPR2

    Background

    Synonyms: Bone morphogenetic protein receptor type-2, BMP type-2 receptor, BMPR-2, Bone morphogenetic protein receptor type II, BMP type II receptor, BMPR-II, BMPR2, PPH1

    Tissue Specificity: Highly expressed in heart and liver.

    Background: Bone morphogenetic protein receptor type II or BMPR2 is a serine/threonine receptor kinase. This gene encodes a member of the bone morphogenetic protein (BMP) receptor family of transmembrane serine/threonine kinases. The ligands of this receptor are BMPs, which are members of the TGF-beta superfamily. BMPs are involved in endochondral bone formation and embryogenesis. These proteins transduce their signals through the formation of heteromeric complexes of two different types of serine (threonine) kinase receptors: type I receptors of about 50-55 kD and type II receptors of about 70-80 kD. Type II receptors bind ligands in the absence of type I receptors, but they require their respective type I receptors for signaling, whereas type I receptors require their respective type II receptors for ligand binding. Mutations in this gene have been associated with primary pulmonary hypertension, both familial and fenfluramine-associated, and with pulmonary venoocclusive disease.

    Molecular Weight

    130 kDa

    UniProt

    Q13873

    Pathways

    Growth Factor Binding
You are here:
Chat with us!